Resources

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 variants in the existing product range of Omnigon BBraun Flexima Active (SAS Code 80142B) in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon F3 AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule.

This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 27 June to 10 July 2022.

This certification statement, signed by Secretary Brendan Murphy on 15 July 2022, certifies that the COVID-19 campaign complies with relevant guidelines and policies.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Natura Durahesive Skin Barrier in subgroup 4(a) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Natura Two-Piece Drainable Pouch in subgroup 6(a) of the Stoma Appliance Scheme (SAS) Schedule.

Frequently asked questions about the Practitioner Review Program.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list the Omnigon BBraun Flexima Active in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule.

This presentation, delivered on 22 July 2022, contains an update to Australia's COVID-19 vaccine rollout.

Information on the definition of inappropriate practice and how it applies to practitioners and corporate entities.

Information on the common compliance issues associated with inappropriate practice based on Professional Services Review outcomes.

Information on how to avoid practicing inappropriately, your responsibilities and sources of information to meet Medicare requirements.

Information about the Practitioner Review Program (PRP) interview

Information about the Practitioner Review Program (PRP) 6-month period of review.

Information about the Practitioner Review Program (PRP) where practitioners are referred to a delegate of the Chief Executive Medicare (delegate) after an interview without a six-month period of review.

Information about the Practitioner Review Program (PRP) and the review by a delegate of the Chief Executive Medicare (delegate).

Information about inappropriate practice and prescribed pattern of services (the 80/20 and 30/20 rules) and which professional attendance services apply.

Information on legislative requirements and considerations when there is a breach of the prescribed pattern of services (the 80/20 and 30/20 rules)

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 21 July 2022.

This brochure provides information about whooping cough (pertussis) vaccination in pregnancy.

This presentation, delivered on 21 July 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.